Evidence map›Paper›PMID 33309924›Full record

ArticleMagnetic resonance imaging2021

Susceptibility artifacts from metallic markers and cardiac catheterization devices on a high-performance 0.55 T MRI system.

Burcu Basar, Merdim Sonmez, Dursun Korel Yildirim, Ram Paul, Daniel A Herzka, Ozgur Kocaturk, Robert J Lederman, Adrienne E Campbell-Washburn

Open access · greenAbstract read
In one paragraph

Article in Magnetic resonance imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Feasibility of tagged MRI at 0.55 T.Magnetic resonance in medicine · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Cardiac MRI at Low Field Strengths.Journal of magnetic resonance imaging : JMRI · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Burcu BasarCardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Merdim SonmezCardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Dursun Korel YildirimCardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA; Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey.
Ram PaulCook Medical, Bloomington, IN, USA.
Daniel A HerzkaCardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Ozgur KocaturkCardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA; Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey.
Robert J LedermanCardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Adrienne E Campbell-WashburnCardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: adrienne.campbell@nih.gov.
National Institutes of Health · USNational Heart Lung and Blood Institute · USCook Medical (United States) · US

Funding

Real-time MRI guided cardiovascular interventionZIAHL005062 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEDERMAN, ROBERT J · 2009 to 2025
$21.6M
MRI catheter design and fabricationZIAHL006041 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEDERMAN, ROBERT J · 2014 to 2025
$12.2M
Real-time cardiovascular MRI and co-registration technical developmentZIAHL006039 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEDERMAN, ROBERT J · 2010 to 2024
$10.3M
Development of high-performance low field MRI technology ZIAHL006257 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CAMPBELL-WASHBURN, ADRIENNE · 2021 to 2025
$8.1M
Innovative Technology for MRI Guided ProceduresZIAHL006213 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CAMPBELL-WASHBURN, ADRIENNE · 2016 to 2025
$5.4M
Intramural NIH HHS ZIA HL006039Intramural NIH HHS ZIA HL006213
6 · The paper itself

Abstract

introductionVisualization of passive devices during MRI-guided catheterizations often relies on a susceptibility artifact from the device itself or added susceptibility markers that impart a unique imaging signature. High-performance low field MRI systems offer reduced RF-induced heating of metallic devices during MRI-guided invasive procedures, but susceptibility artifacts are expected to diminish with field strength, reducing device visualization. In this study, field strength and orientation dependence of artifacts from susceptibility markers and metallic guidewires were evaluated using a prototype high-performance 0.55 T MRI system. MATERIALS AND

methodsArtifact volume from nitinol and stainless steel passive susceptibility markers was quantified using histogram analysis of pixel intensities from three-dimensional gradient echo images at 0.55 T, 1.5 T and 3 T. In addition, visibility of commercially available clinical catheterization devices was compared between 0.55 T and 1.5 T using real-time bSSFP in phantoms and in vivo.

resultsA low-tensile strength stainless-steel marker produced field strength- and orientation-dependent artifact size (1.7 cm DISCUSSION AND

conclusionHigh-susceptibility stainless-steel markers generate field-independent artifacts between 0.55 T, 1.5 T and 3 T, indicating magnetic saturation at fields <0.55 T. Thus, artifact size can be tailored such that interventional devices produce identical imaging signatures across field strengths.

Indexed as

ArtifactsMetalsAlloysCardiac CatheterizationHumansMagnetic Resonance ImagingPhantoms, ImagingAlloysMetalsInterventional MRILow fieldPassive markersSusceptibility artifacts

Identifiers

PMID33309924
PMCPMC8132593
OpenAlexW3112261470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.